CELC

Conviction 13HealthcareScan · Thu, Sep 24, 2026

Celcuity Inc. (CELC) closed at $79.43 (-0.70%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 37, RS Rating 88, -45.2% from its 52-week high, -21.0% year to date. Sector: Healthcare · SERVICES-MEDICAL LABORATORIES.

CELC$79.43-0.70%

ResistanceSupportVol 14Insider sell

Vol MA14 902.73K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Celcuity Inc.SERVICES-MEDICAL LABORATORIESwww.celcuity.com ↗

Price79.43

Change-0.70%

Gap-0.64%

Rel volume1.45×

Avg volume863.96K

Avg $ vol74.79M

SMA 2087.25

SMA 5088.69

SMA 200105.20

Price vs 50-10.45%

Price vs 200-24.49%

MA stackbearish

50/200 cross—

Supertrenddown · 90.71

RSI (14)37

MACD hist-0.70

MACD cross—

Stoch %K / %D11 / 13

ADX (14)21

+DI / −DI16 / 34

RSI divergence—

MACD divergence—

ATR %5.18%

ADR %4.23%

52w high144.98

52w low45.22

From 52w high-45.21%

Above 52w low+75.65%

New 52w highNo

SqueezeOff

Bollinger width25.07%

%B0.14

Donchian pos10.51%

Donchian high98.00

Donchian low77.25

AVWAP (52w high)99.78

vs AVWAP high-20.39%

AVWAP (52w low)97.49

vs AVWAP low-18.52%

OBV trendDown

Chaikin MF (20)-0.18

Today vs 20d1.45×

Avg vol (14d)902.73K

Avg vol (20d)863.96K

Avg $ vol (20d)74.79M

Market cap3.89B

RS Rating88 / 99

RS 3m (vs SPY)-21.69%

RS 6m (vs SPY)-44.75%

RS line new highNo

Trend template1/8

Technical rank13.7

1 week-6.45%

1 month-13.92%

3 months-17.20%

6 months-27.94%

1 year+51.30%

YTD-21.00%

P/E-21.95

P/B-304.10

P/S—

P/FCF-25.32

EPS-3.79

Div yield—

ROE—

ROA-21.38%

Debt/Eq-0.00

Current8.93

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-58.39%

Price target160.50

Target upside102.06%

Analyst ratingBuy

Institutional120.97%

Ent. value3.7B

Revenue—

Net income-78.86M

Gross profit—

Free cash flow-153.53M

IndustrySERVICES-MEDICAL LABORATORIES

ExchangeNasdaq

Shares out48.77M

Employees155

ListedWed, Sep 20, 2017

Free float34.78M

Float %75.2%

Short interest10.69M

Days to cover15.7d

Short volume32.8%

Squeeze score72 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.44 vs −$1.08

Last surprise-33.3% miss

Setup gradeD

Conviction13 / 100

Pattern quality—

Tech rank13.7 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance97.08

Support80.20

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CELC

All disclosures →

No recent disclosed trades by Congress in CELC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CELC · open-market 2 sells

Insider	Side	Shares	Value	Traded	Filed
Sullivan Brian F. Chief Executive Officer · Common Stock · 2026-08-14	Grant	80K	—	2026-08-14	2026-08-18
Sullivan Brian F. Chief Executive Officer · Performance Stock Units · 2026-08-14	Grant	120K	—	2026-08-14	2026-08-18
Laing Lance G. Chief Science Officer · Common Stock · 2026-08-14	Grant	20K	—	2026-08-14	2026-08-18
Laing Lance G. Chief Science Officer · Performance Stock Units · 2026-08-14	Grant	10K	—	2026-08-14	2026-08-18
Hahne Vicky Chief Financial Officer · Common Stock · 2026-08-14	Grant	16K	—	2026-08-14	2026-08-18
Hahne Vicky Chief Financial Officer · Performance Stock Units · 2026-08-14	Grant	10K	—	2026-08-14	2026-08-18
BAKER BROS. ADVISORS LP Insider · Common Stock · 2026-07-14	Sell	261.37K	$27M	2026-07-14	2026-07-16
BAKER BROS. ADVISORS LP Insider · Common Stock · 2026-07-14	Sell	2.84M	$291M	2026-07-14	2026-07-16
Murphy Polly A. Director · Common Stock · 2026-06-05	Grant	1.53K	$0	2026-06-05	2026-06-09
Furcht Leo Director · Common Stock · 2026-06-05	Grant	1.53K	$0	2026-06-05	2026-06-09

SEC filings

EDGAR filings in CELC · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.